Lina S. Sy, MPH

Ms.
Kaiser Permanente Southern California

Disclosure(s): Dynavax: Grant/Research Support; Glaxosmithkline: Grant/Research Support; Moderna: Grant/Research Support; Seqirus: Grant/Research Support

Poster(s):

• 115 - Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET